Dose-Response Relationship of Ambulatory Load and Cartilage - Pilot Study (COMP)
The research question is if there is a dose-response relationship between blood biomarkers for articular cartilage and the magnitude of physiological load. To investigate this load induced biomarker change, the participants will complete a 30-minute walking test under three loading conditions: A: 80%, B: 100% C: 120% of their respective bodyweight (Fig. 1).
The main biomarker we are interested in is called cartilage oligomeric matrix protein (COMP). Serum COMP levels are increased immediately after 30-min running but there is no dose-response relationship shown yet.
Studieöversikt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljerad beskrivning
The current state of research in the field and of our own research clearly shows that the in vivo mechanobiology of articular cartilage is poorly understood. Previous results of changes in cartilage biomarker concentrations after ambulatory exercise raise the following question:
Do load-induced changes in blood biomarkers for articular cartilage (COMP) depend on the physiological load magnitude? To generate initial data for answering this question, we will establish the experimental framework to systematically study the in vivo mechanobiology of human articular cartilage to address the following aims.
- To obtain pilot data for investigating the in vivo dose-response relationship of weight-bearing and blood levels of mechanosensitive biomarker of articular cartilage using controlled load- bearing as experimental paradigm.
- To provide pilot data for comparing ambulatory biomechanics between the controlled load- bearing conditions.
The experimental setting consists of a 30-minutes walking stress test under three loading conditions: A: 80 %, B: 100% and C: 120% bodyweight. Unloading will be achieved through an unloading system and additional loading with an adjustable weight vest. Before and after the walking stress test, venous blood samples will be taken at five time points. The biomarker concentration is measured with a commercial available enzyme-linked immunosorbent assay (ELISA).
Hypothesis Our working hypothesis is that there is a dose-response relationship between the temporarily increased or decreased load and the load-induced change in COMP level in the blood serum. We assume that serum COMP concentration increases with increasing accumulated load on the knee cartilage simulated through the three different loading conditions.
Design The design of the pilot study is a controlled multimodal data collection (biological, biomechanical) with block randomization. Specifically, we will collect blood samples and biomechanical (kinematic and pressure) data. We will determine the relationship between the serum blood concentration and the biomechanical data.
Because this is a cross-over study, all participants will perform the same three walking stress tests but in random order. Each participant of the study will be tested for 2.5 hours on 3 separate days.
Method In this experiment, we will test 24 healthy participants (12 male, 12 female) on 3 test days under three different loading conditions in a randomized block design. On each test day, participants will complete walking stress test for 30-minutes with A: 80%, B: 100% and C: 120% of their bodyweight. Through the modified bodyweight we generate higher or lower forces on the knee cartilage, which should affect the COMP concentration in the blood serum.
To measure the change in serum COMP concentration, blood samples will be taken at five time points before and after the walking stress test. The blood samples are taken by a study nurse. For the venipuncture, a thin, sterile, disposable vein catheter is placed in the antecubital vein. The catheter stays in the vein for the entire 2.5 hours of the experiment. Blood samples will be collected and allowed to clot for 30-minutes. Serum will be separated and frozen in aliquots to -20°C within 1 hour of collection and then transferred for storage at -80°C until assayed. Serum biomarker concentrations will be determined using commercial ELISAs.
Studietyp
Studietyp
Inskrivning (Faktisk)
Inskrivning
Fas
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Basel Stadt
-
Basel, Basel Stadt, Schweiz, 4031
- University Hospital Basel
-
-
Deltagandekriterier
Urvalskriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Age between 18 and 30 years
- being physically active (> 2/week)
- body mass index (BMI) <30 kg/m2
Exclusion Criteria:
- previous knee injury
- neuromuscular condition affecting gait
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Ingen (Open Label)
Antal vapen
Vapen och interventioner
Deltagargrupp / ArmDeltagargrupp / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Inget ingripande: Normal load
Healthy subjects walking for 30 minutes on a treadmill with normal body weight
|
|
|
Experimentell: Increased load
Healthy subjects walking for 30 minutes on a treadmill with 20% additional body weight
|
Participants walk with 120% body weight achieved with a weight vest
|
|
Experimentell: Reduced load
Healthy subjects walking for 30 minutes on a treadmill with 20% lower body weight
|
Participants walk with 80% body weight achieved by a dynamic unloading system
|
Vad mäter studien?
Primära resultatmått
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Load-induced serum Cartilage Oligomeric Matrix Protein concentration
Tidsram: 3 hours
|
Change in serum concentration during 30-minute walking exercise determined by commercial ELISA 30 min before to 2 hours after 30-minute walking exercise
|
3 hours
|
Sekundära resultatmått
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Overall ground reaction force impulse
Tidsram: 30 minutes
|
Area under the ground reaction curve multiplied by number of steps taken during 30-minute walking exercise
|
30 minutes
|
|
Dynamic range of motion lower extremity joints
Tidsram: 30 minutes
|
Min to max joint angles (ankle, knee, hip) measured using RehaGait (inertial measurement units)
|
30 minutes
|
Andra resultatmått
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Age
Tidsram: At enrollment
|
Age in years
|
At enrollment
|
|
Sex
Tidsram: At enrollment
|
male or female
|
At enrollment
|
|
Body mass index
Tidsram: At enrollment
|
BMI in kg/m2
|
At enrollment
|
|
Knee function
Tidsram: At enrollment
|
Knee Osteoarthritis Outcome Score measured by questionnaire (best score: 100 - no limitations; worst score: 0)
|
At enrollment
|
Samarbetspartners och utredare
Sponsor
Sponsor
Samarbetspartners
Samarbetspartners
Utredare
Utredare
- Huvudutredare: Annegret Muendermann, PhD, University Hospital, Basel, Switzerland
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Studiestart
Primärt slutförande (Faktisk)
Primärt slutförande
Avslutad studie (Faktisk)
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Första postat
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste uppdatering publicerad
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
Andra studie-ID-nummer
- 2017-01006
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Friska
-
NCT07551557Har inte rekryterat ännuHepatic Impairment and Healthy Female
-
NCT07491289Har inte rekryterat ännuHepatic Impairment and Healthy Female
-
NCT07513766RekryteringHealthy Controls Group - ålders- och könsmatchad | Repetitivt negativt tänkande
-
NCT02585791AvslutadHealthy Lifetime Icke-rökare
-
NCT06631261RekryteringBronkiektasi Vuxen | Healthy Controls Group - ålders- och könsmatchad
-
NCT06880640RekryteringHealthy Controls Group - ålders- och könsmatchad | Borderline personlighetsstörning (BPD)
-
NCT07505355RekryteringMultipel skleros | Healthy Controls Group - ålders- och könsmatchad
-
NCT03050593AvslutadPatienter med hjärtsvikt och konserverad ejektionsfraktion - HFpEF | Patienter med hjärtsvikt med reducerad ejektionsfraktion - HFrEF | Healthy Controls Group - ålders- och könsmatchad
-
NCT07245303RekryteringMuskuloskeletal smärta | Fibromyalgi | Healthy Controls Group - ålders- och könsmatchad
-
NCT03940677AvslutadParkinsons sjukdom | Healthy Controls Group - ålders- och könsmatchad
Kliniska prövningar på Increased load
-
NCT06693479RekryteringSkulderartros | Reumatoid artrit (RA) | Rotatorcuff-relaterad axelsmärta
-
NCT07450794Har inte rekryterat ännuAnestesiläkarbelastning
-
NCT05695911Aktiv, inte rekryterandeAmputation | Transfemoral amputation | Osseointegration
-
NCT00620763Avslutad
-
NCT03767231Har inte rekryterat ännu
-
NCT05144776Avslutad
-
NCT06603532AvslutadKnäskador | Knäoperation | Artrogen muskelhämning
-
NCT00039741Avslutad
-
NCT04014179AvslutadHepatit C | Hepatit C, kronisk